CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
The Zeltiq CoolSculpting Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02324816
NCT02324816N/ACompleted

Non-Invasive Fat Layer Reduction in the Lateral Thighs With a Cryolipolysis System Using a Colder Treatment Parameter

Zeltiq Aesthetics·interventional·Posted Dec 24, 2014·Updated Dec 28, 2021

In Brief

A clinical study evaluating The Zeltiq CoolSculpting System for Body Fat Disorder. Completed, enrolled 19 participants across 1 site.

Detailed Summary

Evaluate the performance of a cryolipolysis system using a colder treatment parameter for non-invasive reduction of subcutaneous fat in the lateral thighs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 24, 2014
Enrollment StartNov 14, 2014
Primary CompletionMar 13, 2015
Study CompletionMar 31, 2015
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 11.5 years ago

Interventions

The Zeltiq CoolSculpting Systemdevice

The CoolSculpting System delivers non-invasive cooling for the reduction of subcutaneous fat.